Information Visualization Platform for Postmarket Surveillance Decision Support
- 1 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 43 (9), 905-915
- https://doi.org/10.1007/s40264-020-00945-0
Abstract
Introduction The US FDA receives more than 2 million postmarket reports each year. Safety Evaluators (SEs) review these reports, as well as external information, to identify potential safety signals. With the increasing number of reports and the size of external information, more efficient solutions for data integration and decision making are needed. Objectives The aim of this study was to develop an interactive decision support application for drug safety surveillance that integrates and visualizes information from postmarket reports, product labels, and biomedical literature. Methods We conducted multiple meetings with a group of seven SEs at the FDA to collect the requirements for the Information Visualization Platform (InfoViP). Using infographic design principles, we implemented the InfoViP prototype version as a modern web application using the integrated information collected from the FDA Adverse Event Reporting System, the DailyMed repository, and PubMed. The same group of SEs evaluated the InfoViP prototype functionalities using a simple evaluation form and provided input for potential enhancements. Results The SEs described their workflows and overall expectations around the automation of time-consuming tasks, including the access to the visualization of external information. We developed a set of wireframes, shared them with the SEs, and finalized the InfoViP design. The InfoViP prototype architecture relied on a javascript and a python-based framework, as well as an existing tool for the processing of free-text information in all sources. This natural language processing tool supported multiple functionalities, especially the construction of time plots for individual postmarket reports and groups of reports. Overall, we received positive comments from the SEs during the InfoViP prototype evaluation and addressed their suggestions in the final version. Conclusions The InfoViP system uses context-driven interactive visualizations and informatics tools to assist FDA SEs in synthesizing data from multiple sources for their case series analyses.Funding Information
- U.S. Food and Drug Administration (2U01FD005942-03 REVISED)
This publication has 13 references indexed in Scilit:
- Towards Automating Adverse Event Review: A Prediction Model for Case Report UtilityDrug Safety, 2020
- DIVA: Exploration and Validation of Hypothesized Drug‐Drug InteractionsComputer Graphics Forum, 2019
- Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminologyJournal of Biomedical Informatics, 2018
- Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting systemJournal of the American Medical Informatics Association, 2017
- Decision support environment for medical product safety surveillanceJournal of Biomedical Informatics, 2016
- vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality IssuesDrug Safety, 2013
- Application of Information Retrieval Approaches to Case Classification in the Vaccine Adverse Event Reporting SystemDrug Safety, 2013
- The contribution of the Vaccine adverse event Text Mining system to the classification of possible Guillain-Barré Syndrome reportsApplied Clinical Informatics, 2013
- Vaccine adverse event text mining system for extracting features from vaccine safety reportsJournal of the American Medical Informatics Association, 2012
- Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selectionJournal of the American Medical Informatics Association, 2011